Login / Signup

Immunomodulatory Agents for Multiple Myeloma.

Jiří MinaříkSabina Sevcikova
Published in: Cancers (2022)
The treatment of multiple myeloma (MM) has undergone a significant paradigm shift in the last 20 years, from conventional chemotherapy to more tumor-specific treatments, based on the interference with pathogenesis of the malignant clone as well as the bone microenvironment [...].
Keyphrases
  • multiple myeloma
  • stem cells
  • locally advanced
  • squamous cell carcinoma
  • bone loss
  • body composition
  • bone regeneration
  • rectal cancer